EASD: Petrelintide Achieves Weight Loss for Adults With Obesity

WEDNESDAY, Oct. 14, 2026-- The amylin-based analog petrelintide achieves meaningful weight reduction for adults with obesity, according to a study published online Sept. 29 in The Lancet Diabetes & Endocrinology to coincide with the annual...